Not sure you are correct regarding the tasteless capsules. The announcement that mentioned it noted this:
"A further observation of the Trial Safety Committee was in regard to the taste and palatability of PPL-1. It was noted that as the quantity of drug being consumed orally increases with escalating doses, there may be some challenges in patients tolerating the treatment due to the taste"
They were just making an observation that palatability may become an issue and there may be challenges to overcome. So I do not think at this early stage a tasteless capsule is holding anything up.
Not sure you are correct regarding the tasteless capsules. The...
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $85.12M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 18.0¢ | 17.5¢ | $50.92K | 290.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 152309 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 329859 | 3 |
View Market Depth
| Last trade - 15.48pm 11/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |